Stay updated on Biomarker Therapy for AR-V7+ Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the Biomarker Therapy for AR-V7+ Prostate Cancer Clinical Trial page.

Latest updates to the Biomarker Therapy for AR-V7+ Prostate Cancer Clinical Trial page
- CheckyesterdayChange DetectedThe page now includes a Locations section with Maryland listed as a site. The Maryland Locations entry was removed, the HHS Vulnerability Disclosure link was removed, and the page revision was updated from v3.3.2 to v3.3.3.SummaryDifference0.2%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check24 days agoChange DetectedThe Publications section now states that publications are provided voluntarily by the person entering information and relate to the study results. The page also displays a new revision label, v3.3.2, replacing v3.2.0.SummaryDifference0.1%

- Check31 days agoChange DetectedRemoval of the government-funding lapse notice banner. The page now displays the study details without that notice.SummaryDifference0.3%

- Check52 days agoChange DetectedThe new screenshot shows no substantive updates to study details, eligibility criteria, outcomes, or locations; only minor formatting changes are visible. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check74 days agoChange Detected- Added a government-operating-status notice and a link to official sources, indicating the page may have dynamic status information. - Updated version from v3.1.0 to v3.2.0, signaling a new release.SummaryDifference3%

- Check81 days agoChange DetectedUpdated page content with a broader set of immunology terms and an upgraded revision version v3.1.0, replacing v3.0.2.SummaryDifference1.0%

Stay in the know with updates to Biomarker Therapy for AR-V7+ Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Biomarker Therapy for AR-V7+ Prostate Cancer Clinical Trial page.